November 5, 2009
London Times
Nanoparticle cancer therapy targets tumours and dodges immune system
By Mark Henderson
A nanotechnology therapy that targets cancer with a “stealth smart bomb”
is to begin patient trials next year in the first clinical test of a
pioneering approach to medicine, The Times has learnt.
The nanoparticle, which targets tumour cells while evading the body’s
immune system, promises to deliver larger and more effective doses of
drugs to cancers, while simultaneously sparing patients many of the
distressing side-effects of chemotherapy ....
read
the entire piece
